Post ESMO Webinars:
Expanding the HCC Treatment Paradigm: Applying Emerging Data Across a Broader Range of Eligible Patients – Presented by Mark Yarchoan, MD, Associate Professor of Oncology, Johns Hopkins School of Medicine
Precision Medicine Lung Cancer Tumor Board Every Other Tuesday at 8:30pm ET
Join host Charu Aggarwal, MD, MPH, Penn Medicine and guest panel panel for the bi- weekly Precision Medicine Lung Cancer Tumor Board, every other Tuesday at 8:30pm ET.
- 10/27/26 8:30pm ET Advances in Targeting RAS in NSCLC
- 11/10/26 8:30pmET Tagrisso: Update on Long Term OS Benefit-How Long Should it be Administered
- 11/17/26 8:00pmET LIBRETTO-432: Adjuvant Selpercatinib in Early-Stage RET Fusion-Positive NSCLC
- 11/30/26 8:30pmET
- 12/7/26 8:30pmET
Have a clinical case you would like to discuss with the Omni Oncology Virtual Molecular Tumor Board? Submit any solid tumor case or questions relating to molecular diagnostics or ctDNA for the VMTB series to chweaver@omnihealthmedia.com
Stay up to date! Don’t miss this opportunity to enhance your clinical practice with cutting-edge insights, access to experts, and real world case discussions. Register for weekly and monthly newsletter notification of upcoming programs and on demand access here.